AdvisorShares Trust has recently filed a summary prospectus for its AdvisorShares MSOS Daily Leveraged ETF, a move that highlights the company’s commitment to providing innovative investment options in the cannabis sector. The ETF aims to deliver daily investment results that correspond to approximately two times (2x) the return of the AdvisorShares Pure US Cannabis ETF. This filing is significant as it underscores the growing interest in cannabis-related investments and the complexities involved in leveraged financial products.

AdvisorShares Trust, based in Bethesda, Maryland, is an investment firm focused on developing and managing exchange-traded funds (ETFs). The company operates under the Central Index Key (CIK) 0001408970 and has a range of recent filings that indicate active engagement in the investment landscape. The firm’s latest filings include several 497K forms, with the most recent dated October 30, 2026.

The filing states, "The Fund seeks daily investment results that correspond to approximately two times (2x) the return of AdvisorShares Pure US Cannabis ETF," emphasizing the ETF's unique structure. However, it also warns that the return for periods longer than a single trading day may not align with the expected 200% of the US Cannabis ETF's performance due to the effects of compounding and market volatility.

This update may affect sophisticated investors looking for leveraged exposure to the cannabis market, as the fund is tailored for those who understand the associated risks. The filing highlights the potential for significant losses, stating, "An investor could lose the full principal value of their investment within a single day." This cautionary note reflects the high-risk nature of leveraged ETFs, particularly in the volatile cannabis sector.

The filing does not specify what actions will follow this prospectus submission, leaving investors and market watchers to await further developments from AdvisorShares Trust.